A study of over 450,000 NSTEMI admissions reveals that diabetics face disparities in care, with less invasive treatment ...
MedPage Today on MSN3d
Protein Drivers of Heart Attack Risk Disproportionately Affect WomenWhile women are thought to generally have greater protection than men against CVD due to estrogen, women have been shown to ...
The following is a summary of “Role of Inflammation in Early Left Ventricular Thrombus Formation Following ST-Elevation Myocardial Infarction—A Matched Case-Control Study,” published in the October ...
The Global Myocardial Infarction Therapeutics Market is estimated to be valued at USD 15.56 billion in 2023 and is projected to grow at a CAGR of 4.19% over the forecast period 2024-2032. Read the ...
Early use of mechanical circulatory support did not reduce 6-month all-cause mortality. 2. MCS was associated with increased ...
18 The time relations between the onset of myocardial infarction and death have not been adequately studied. Most reviews concerning the immediate prognosis of myocardial infarction lump all ...
ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug ...
A multicenter study led by Hospital Clínico San Carlos and the CNIC has validated a new preoperative planning method using ...
A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD.
The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study published online Aug. 4 in Frontiers in Neurology. Zhemin Pan ...
Myocardial Infarction, Cardiovascular Disease, Prevention, Challenges, Review Abdin, A. (2024) Myocardial Infarction and the Prevention Strategies Keeping it at Bay: A Narrative Review. Open Access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback